| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 5. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | dorzolamide/timolol (COSOPT iMulti®) |
| Formulation | 20mg/ml + 5mg/ml eye drops |
| Reference number | 3945 |
| Indication | Treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or pseudoexfoliative glaucoma when topical beta blocker monotherapy is not sufficient |
| Company | Santen Oy |
| BNF chapter | Eye |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 26/07/2018 |